Precision Biosensor Inc.
Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea. It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform. The company was founded in 2009 and is headquartered in Daejeon, South Korea.
Precision Biosensor Inc. (335810) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.009x
Based on the latest financial reports, Precision Biosensor Inc. (335810) has a cash flow conversion efficiency ratio of 0.009x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩173.41 Million) by net assets (₩19.48 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Precision Biosensor Inc. - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Precision Biosensor Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Precision Biosensor Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Precision Biosensor Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ascendant Resources Inc
OTCQB:ASDRF
|
0.017x |
|
Bartronics India Limited
NSE:ASMS
|
N/A |
|
Dynasty Gold Corp
PINK:DGDCF
|
0.010x |
|
Gesundheitswelt Chiemgau AG
MU:JTH
|
N/A |
|
Bluelinea SA
PA:ALBLU
|
-0.615x |
|
Electric Power Technology Limited
TWO:4529
|
-0.046x |
|
ALFOT Technologies Co., Ltd.
TWO:4553
|
-0.011x |
|
KD Chem Co. Ltd
KQ:221980
|
0.024x |
Annual Cash Flow Conversion Efficiency for Precision Biosensor Inc. (2017–2024)
The table below shows the annual cash flow conversion efficiency of Precision Biosensor Inc. from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩25.70 Billion | ₩-1.44 Billion | -0.056x | +7.86% |
| 2023-12-31 | ₩32.03 Billion | ₩-1.95 Billion | -0.061x | +20.99% |
| 2022-12-31 | ₩33.38 Billion | ₩-2.58 Billion | -0.077x | +35.29% |
| 2021-12-31 | ₩38.35 Billion | ₩-4.57 Billion | -0.119x | +8.27% |
| 2020-12-31 | ₩37.22 Billion | ₩-4.84 Billion | -0.130x | +29.13% |
| 2019-12-31 | ₩11.32 Billion | ₩-2.08 Billion | -0.183x | -109.79% |
| 2018-12-31 | ₩-1.52 Billion | ₩-2.85 Billion | 1.875x | +270.01% |
| 2017-12-31 | ₩2.55 Billion | ₩-2.81 Billion | -1.103x | -- |